Long-term survival with eribulin monotherapy after whole brain radiation therapy in a patient with brain metastasis from breast cancer

Asian J Surg. 2020 Oct;43(10):1008-1009. doi: 10.1016/j.asjsur.2020.05.002. Epub 2020 Jul 4.

Authors

Sung Ui Jung¹, Chang Wan Jeon¹, Jin Hyuk Choi²

Affiliations

¹ Division of Breast Surgery, Department of Surgery, University of Kosin College of Medicine, Kosin Univ. Gospel Hospital, Busan, South Korea.
² Division of Breast Surgery, Department of Surgery, University of Kosin College of Medicine, Kosin Univ. Gospel Hospital, Busan, South Korea. Electronic address: drchoijinhyuk@gmail.com.

PMID: 32631621
DOI: 10.1016/j.asjsur.2020.05.002

No abstract available

Keywords: Brain metastasis; Breast cancer; Eribulin; Palliative chemotherapy; Whole brain radiation therapy.

Publication types

Case Reports
Letter

MeSH terms

Blood-Brain Barrier / metabolism
Brain Neoplasms / diagnostic imaging
Brain Neoplasms / drug therapy*
Brain Neoplasms / radiotherapy
Brain Neoplasms / secondary*
Breast Neoplasms / pathology*
Carcinoma, Ductal / diagnostic imaging
Carcinoma, Ductal / drug therapy*
Carcinoma, Ductal / radiotherapy
Carcinoma, Ductal / secondary*
Combined Modality Therapy
Female
Furans / metabolism
Furans / therapeutic use*
Humans
Ketones / metabolism
Ketones / therapeutic use*
Magnetic Resonance Imaging
Middle Aged
Radiotherapy / methods*
Survival Rate
Time Factors
Treatment Outcome

Substances

Furans
Ketones
eribulin